Cellular therapies and biotherapies are growing areas of medicine that are transforming patient care. AABB works with the cellular therapies community to drive policies that ensure patient access, advance research, increase the supply and safety biological products, and expand coverage for these transformative therapies.
NHLBI Pauses SCD Gene Therapy Trial
February 24, 2021
FDA Sends California Company Untitled Letter Regarding Unapproved Claims for Cellular Products
February 23, 2021
CAR T-Cell Therapy May Be Less Successful in Patients With Immune Dysregulation
February 23, 2021